Detalhe da pesquisa
1.
Comparison of middle- and bottom-up mass spectrometry in forced degradation studies of bevacizumab and infliximab.
J Pharm Biomed Anal
; 235: 115596, 2023 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37540995
2.
Forced Degradation Testing as Complementary Tool for Biosimilarity Assessment.
Bioengineering (Basel)
; 6(3)2019 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31330921